Status:
RECRUITING
Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure
Lead Sponsor:
NYU Langone Health
Conditions:
Acute Decompensated Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective cohort study for 50 patients admitted to the cardiac care unit requiring clinically-indicated diuretic therapy for congestive heart failure. The purpose of this study is to asses...
Eligibility Criteria
Inclusion
- Diagnosis of congestive acute decompensated heart failure (preserved or reduced ejection fraction) requiring clinically indicated IV diuresis
- Admission to coronary/cardiac intensive care unit or cardiac step down unit
- Able to provide written informed consent
- Anticipated need for IV diuretics \> 24 hrs
Exclusion
- Prisoner, pregnancy or post-partum stage, or age \< 18 years
- Known allergy to sensory material or gel
- End stage renal disease or need for CRRT
- Inability or contraindication to do a passive leg raise with both extremities (i.e., balloon pump, impella, spinal injury, amputation)
- Other situation that might increase subject risk, interfere with study procedures, or confound study findings based on the opinion of the clinician/investigator
- Inability to provide informed consent
Key Trial Info
Start Date :
August 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05240651
Start Date
August 30 2022
End Date
July 1 2026
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016